183 related articles for article (PubMed ID: 7795587)
21. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
22. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
[TBL] [Abstract][Full Text] [Related]
23. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
24. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
Hamilton TB; Barilla KC; Romaniuk PJ
Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
Matsuzawa-Watanabe Y; Inoue J; Semba K
Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
[TBL] [Abstract][Full Text] [Related]
26. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
27. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis.
Denamur E; Bocquet N; Baudouin V; Da Silva F; Veitia R; Peuchmaur M; Elion J; Gubler MC; Fellous M; Niaudet P; Loirat C
Kidney Int; 2000 May; 57(5):1868-72. PubMed ID: 10792605
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
Laity JH; Chung J; Dyson HJ; Wright PE
Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
[TBL] [Abstract][Full Text] [Related]
29. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
[TBL] [Abstract][Full Text] [Related]
30. Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins.
Holmes G; Boterashvili S; English M; Wainwright B; Licht J; Little M
Biochem Biophys Res Commun; 1997 Apr; 233(3):723-8. PubMed ID: 9168922
[TBL] [Abstract][Full Text] [Related]
31. Did nucleotides or amino acids drive evolutionary conservation of the WT1 +/-KTS alternative splice?
Davies RC; Bratt E; Hastie ND
Hum Mol Genet; 2000 May; 9(8):1177-83. PubMed ID: 10767342
[TBL] [Abstract][Full Text] [Related]
32. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
33. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.
Schneider S; Wildhardt G; Ludwig R; Royer-Pokora B
Hum Genet; 1993 Jul; 91(6):599-604. PubMed ID: 8393425
[TBL] [Abstract][Full Text] [Related]
34. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
35. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
Kohsaka T; Tagawa M; Takekoshi Y; Yanagisawa H; Tadokoro K; Yamada M
Hum Mutat; 1999; 14(6):466-70. PubMed ID: 10571943
[TBL] [Abstract][Full Text] [Related]
36. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of PDGF-A and TGF-beta by +KTS WT1 deletion mutants and a mutant mimicking Denys-Drash syndrome.
Jin DK; Kang SJ; Kim SJ; Bang EH; Hwang HZ; Tadokoro K; Yamada M; Kohsaka T
Ren Fail; 1999 Nov; 21(6):685-94. PubMed ID: 10586431
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
39. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
40. Recognition mechanism of Wilms' tumour suppressor protein and DNA triplets: insights from molecular dynamics simulation and free energy analysis.
Zhang LF; Zheng QC; Zhang HX
J Biomol Struct Dyn; 2019 Feb; 37(3):562-575. PubMed ID: 29375007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
